Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Boston Scientific Corporation (BSX) stocks in Canada

Learn how to easily invest in Boston Scientific Corporation stocks.

Boston Scientific Corporation is a medical devices business based in the US. Boston Scientific Corporation stocks (BSX.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $40.43 – a decrease of 0.94% over the previous week. Boston Scientific Corporation employs 38,000 staff and has a trailing 12-month revenue of around $11.5 billion.

How to buy shares in Boston Scientific Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BSX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Boston Scientific Corporation stock price (NYSE:BSX)

Use our graph to track the performance of BSX stocks over time.

Boston Scientific Corporation shares at a glance

Information last updated 2022-01-22.
Latest market close$43.04
52-week range$35.05 - $46.29
50-day moving average $41.73
200-day moving average $42.93
Wall St. target price$51.04
PE ratio 55.8778
Dividend yield N/A (0%)
Earnings per share (TTM) $0.77

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Boston Scientific Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Boston Scientific Corporation price performance over time

Historical closes compared with the close of $43.04 from 2022-01-26

1 week (2022-01-21) 0.16%
1 month (2021-12-27) -0.19%
3 months (2021-10-28) -0.46%
6 months (2021-07-28) -5.26%
1 year (2021-01-28) 18.44%
2 years (2020-01-28) -0.94%
3 years (2019-01-28) 16.80%
5 years (2017-01-27) 80.31%

Is Boston Scientific Corporation under- or over-valued?

Valuing Boston Scientific Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Boston Scientific Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Boston Scientific Corporation's P/E ratio

Boston Scientific Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 56x. In other words, Boston Scientific Corporation shares trade at around 56x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Boston Scientific Corporation's PEG ratio

Boston Scientific Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.5118. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Boston Scientific Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Boston Scientific Corporation's EBITDA

Boston Scientific Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.1 billion.

The EBITDA is a measure of a Boston Scientific Corporation's overall financial performance and is widely used to measure a its profitability.

Boston Scientific Corporation financials

Revenue TTM $11.5 billion
Operating margin TTM 17.25%
Gross profit TTM $6.8 billion
Return on assets TTM 3.94%
Return on equity TTM 7.22%
Profit margin 10.08%
Book value $11.55
Market capitalisation $61.2 billion

TTM: trailing 12 months

Boston Scientific Corporation's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Boston Scientific Corporation.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Boston Scientific Corporation's total ESG risk score

Total ESG risk: 29.23

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Boston Scientific Corporation's overall score of 29.23 (as at 01/01/2019) is nothing to write home about – landing it in it in the 57th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Boston Scientific Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Boston Scientific Corporation's environmental score

Environmental score: 1.51/100

Boston Scientific Corporation's social score

Social score: 12.87/100

Boston Scientific Corporation's governance score

Governance score: 7.87/100

Boston Scientific Corporation's controversy score

Controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Boston Scientific Corporation scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Boston Scientific Corporation hasn't always managed to keep its nose clean.

Boston Scientific Corporation share dividends

We're not expecting Boston Scientific Corporation to pay a dividend over the next 12 months.

Have Boston Scientific Corporation's shares ever split?

Boston Scientific Corporation's shares were split on a 2:1 basis on 6 November 2003. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Boston Scientific Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Boston Scientific Corporation shares which in turn could have impacted Boston Scientific Corporation's share price.

Boston Scientific Corporation share price volatility

Over the last 12 months, Boston Scientific Corporation's shares have ranged in value from as little as $35.045 up to $46.29. A popular way to gauge a stock's volatility is its "beta".

BSX.US volatility(beta: 0.88)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Boston Scientific Corporation's is 0.8824. This would suggest that Boston Scientific Corporation's shares are less volatile than average (for this exchange).

Boston Scientific Corporation overview

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site